1. EuroPCR25th annual meeting of theEuropean Association ofPercutaneous CardiovascularInterventions (EAPCI)Paris20-23 May 2014

2. EuroPCR 2014Paris20-23 May 2014Emerging solutions for distal leftmain and other complex bifurcationsCommentary:Dr Greg StarmerCairns Hospital 3. Date of preparation May 2014 BRI001132Disclaimer AstraZeneca abides by the Medicines Australia Code of Conduct (Edition 17) andAstraZeneca Global Policies, and as such will not engage in the promotion ofunregistered products or unapproved indications. These highlights have been suggested by a group of cardiologists who attendedEuroPCR 2014, compiled by an external medical writer and sponsored byAstraZeneca. AstraZeneca has obtained permission from EuroPCR, to utilise the selected content foreducational purposes. Statements of fact and opinions expressed are those of the speakers individually and,unless expressly stated to the contrary, are not the opinion or position of AstraZeneca.AstraZeneca does not endorse or approve, and assumes no responsibility for, thecontent, accuracy, or completeness of the information presented. Presentations areintended for educational purposes only and do not replace independent professionaljudgement. Please refer to the appropriate approved Product Information before prescribing anyagents mentioned in these highlights.AstraZeneca Pty Ltd, Alma Road, North Ryde 2113 ABN: 54 009 682 311 4. EuroPCR 2014Paris20-23 May 2014 5. EuroPCR 2014Paris20-23 May 2014 6. EuroPCR 2014Paris20-23 May 2014EBC = European Bifurcation Club 7. EuroPCR 2014Paris20-23 May 2014PCI vs CABG: NOBEL and EXCEL trials expected toreport in 2016 8. EuroPCR 2014Paris20-23 May 2014 9. EuroPCR 2014Paris20-23 May 2014 10. EuroPCR 2014Paris20-23 May 2014 11. EuroPCR 2014Paris20-23 May 2014 12. EuroPCR 2014Paris20-23 May 2014 13. EuroPCR 2014Paris20-23 May 2014 14. EuroPCR 2014Paris20-23 May 2014 15. EuroPCR 2014Paris20-23 May 2014 16. EuroPCR 2014Paris20-23 May 2014 17. EuroPCR 2014Paris20-23 May 2014 18. EuroPCR 2014Paris20-23 May 2014 19. EuroPCR 2014Paris20-23 May 2014 20. EuroPCR 2014Paris20-23 May 2014 21. EuroPCR 2014Paris20-23 May 2014 22. EuroPCR 2014Paris20-23 May 2014 23. EuroPCR 2014Paris20-23 May 2014 24. EuroPCR 2014Paris20-23 May 2014 25. EuroPCR 2014Paris20-23 May 2014Commentary: Dr Greg Starmer Guidelines for the management of distal main lesions and othercomplex bifurcations cannot be prescriptive. They recognise thatanatomical, clinical, technical and local factors need to be considered.Local factors include resources and operator experience. The current consensus is that provisional single side branch stenting isgenerally preferable unless the side branch is at risk, in which case aninitial two-stent strategy may be appropriate. Importantly, the intervention should always be planned in advancerather than adopted ad hoc, using two wires and drug-eluting stents.